CIK 0001035422 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
CTT PHARMACEUTICAL HOLDINGS, INC.
Sign in to watch- Ticker
- CTTH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- operating
- EIN
- 113763974
- Phone
- 813-606-0060
- Business address
- 1646 W. SNOW AVE SUITE 138, TAMPA, FL, 33606
- Former names
- Mindesta Inc., INDUSTRIAL MINERALS INC, PNW CAPITAL INC, WINCHESTER MINING CORP
- Open-market buys, last 90 days
- $4,917
- in 15 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$4,917. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-31 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +7,000 | $0.06 | $420 | 7,774,756 |
| 2025-09-23 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +6,815 | $0.06 | $409 | 7,767,756 |
| 2025-08-02 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +44,085 | $0.05 | $2K | 7,760,941 |
| 2025-08-01 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Grant or award | +750,000 | $0.04 | $30K | 7,716,856 |
| 2025-08-01 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +15,800 | $0.04 | $553 | 6,966,856 |
| 2025-07-08 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +8,000 | $0.03 | $240 | 6,951,056 |
| 2025-06-26 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +39,600 | $0.03 | $990 | 6,943,056 |
| 2025-06-23 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +16,100 | $0.03 | $403 | 6,903,456 |
| 2025-06-09 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +82,158 | $0.05 | $4K | 6,832,558 |
| 2025-04-11 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Grant or award | +150,000 | $0.06 | $9K | 6,750,400 |
| 2025-04-09 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +9,984 | $0.07 | $649 | 6,600,400 |
| 2025-03-31 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +15,510 | $0.05 | $776 | 6,590,416 |
| 2025-03-11 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +5,400 | $0.06 | $324 | 6,574,906 |
| 2025-03-07 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +11,950 | $0.09 | $1K | 6,569,506 |
| 2025-02-05 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +5,200 | $0.12 | $624 | 6,557,556 |
| 2024-11-25 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +23,346 | $0.06 | $1K | 5,818,846 |
| 2024-09-11 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +750 | $0.06 | $41 | 5,045,500 |
| 2024-09-11 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Grant or award | +750,000 | $0.04 | $30K | 5,795,500 |
| 2024-09-11 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +1,100 | $0.06 | $61 | 5,044,750 |
| 2024-08-27 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +550 | $0.06 | $33 | 5,042,650 |
Page 2 of 6 · 110 trades